SERPING1 and hereditary angioedema: IV C1‐INH is recommended for LTP in pediatric patients with HAE aged 6 to <12 years.IV C1‐INH, SC C1‐INH and lanadelumab are recommended for LTP in pediatric patients with HAE aged ≥12 years.Androgen use is considered contraindicated in pediatric patients with HAE.Tranexamic acid is not recommended despite existing approval.